Food Deserts, Swamps Linked to Increased Risk of Death From Obesity-Related Cancers
US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.
Diagnosis & Disease Information
Belantamab Mafodotin Deemed Safe, Effective in Real-World MM Population
Belantamab mafodotin has shown clinical activity and a manageable safety profile in a real-world population of patients with relapsed/refractory multiple myeloma.
Lack of Access to Abortion Has Had a Negative Impact on Cancer Care
Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.
Motixafortide Increases HSPC Mobilization in MM Patients
Adding motixafortide to G-CSF increases mobilization of CD34+ HSPCs in patients with multiple myeloma, a phase 3 trial suggests.
Cancer Death Rates Higher in NHPI Patients Than in Asian Patients
A new study has revealed “stark” differences in cancer death rates between Asian patients and NHPI patients in the US, according to researchers.
Associations Between Cancer and COVID-19 Death “More Substantial” in Women
The risk of in-hospital death from COVID-19 for patients with cancer differs by sex and cancer type, according to a new study.
Algorithm Reduces Falls Among Hematology/Oncology Patients
An algorithm can help nurses reduce falls with injury in hematology/oncology inpatients, a study suggests.
Intervention Training Oncology Nurses Improves Management of CAR-T Therapy
A training program successfully taught nurses how to manage patients receiving CAR T-cell therapy.
Ibrutinib No Longer Approved for MCL, MZL: How This Change Will Affect Patients
The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say.
Lisocabtagene Maraleucel Bests Standard Care in LBCL
Second-line lisocabtagene maraleucel improved outcomes over standard care in patients with primary refractory or early relapsed large B-cell lymphoma in the phase 3 TRANSFORM study.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...